vs

Side-by-side financial comparison of FOSTER L B CO (FSTR) and NATIONAL PRESTO INDUSTRIES INC (NPK). Click either name above to swap in a different company.

NATIONAL PRESTO INDUSTRIES INC is the larger business by last-quarter revenue ($164.0M vs $160.4M, roughly 1.0× FOSTER L B CO). On growth, FOSTER L B CO posted the faster year-over-year revenue change (25.1% vs 21.7%). FOSTER L B CO produced more free cash flow last quarter ($19.8M vs $12.4M). Over the past eight quarters, NATIONAL PRESTO INDUSTRIES INC's revenue compounded faster (46.3% CAGR vs 13.6%).

Foster L B Co. is a U.S.-headquartered industrial manufacturing firm that develops, produces and distributes engineered access solutions, construction components, and rail infrastructure products. It serves commercial construction, transportation, and industrial end markets across North America and selected international regions.

National Presto Industries is a company founded in 1905 in Eau Claire, Wisconsin. Originally called "Northwestern Steel and Iron Works" the company changed its name to the "National Pressure Cooker Company" in 1929 and then National Presto Industries, Inc. 1953. The company originally produced pressure canners for commercial, and later home, use. Beginning in 1939, the company introduced small home-use cooking appliances. The company was admitted to the New York Stock Exchange on March 3, 1969.

FSTR vs NPK — Head-to-Head

Bigger by revenue
NPK
NPK
1.0× larger
NPK
$164.0M
$160.4M
FSTR
Growing faster (revenue YoY)
FSTR
FSTR
+3.4% gap
FSTR
25.1%
21.7%
NPK
More free cash flow
FSTR
FSTR
$7.4M more FCF
FSTR
$19.8M
$12.4M
NPK
Faster 2-yr revenue CAGR
NPK
NPK
Annualised
NPK
46.3%
13.6%
FSTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FSTR
FSTR
NPK
NPK
Revenue
$160.4M
$164.0M
Net Profit
$2.4M
Gross Margin
19.7%
16.9%
Operating Margin
4.9%
11.4%
Net Margin
1.5%
Revenue YoY
25.1%
21.7%
Net Profit YoY
1098.3%
EPS (diluted)
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FSTR
FSTR
NPK
NPK
Q4 25
$160.4M
$164.0M
Q3 25
$138.3M
$115.5M
Q2 25
$143.6M
$120.4M
Q1 25
$97.8M
$103.6M
Q4 24
$128.2M
$134.7M
Q3 24
$137.5M
$91.8M
Q2 24
$140.8M
$85.1M
Q1 24
$124.3M
$76.7M
Net Profit
FSTR
FSTR
NPK
NPK
Q4 25
$2.4M
Q3 25
$4.4M
$5.3M
Q2 25
$2.9M
$5.2M
Q1 25
$-2.1M
$7.6M
Q4 24
$-242.0K
Q3 24
$35.9M
$8.1M
Q2 24
$2.8M
$6.1M
Q1 24
$4.4M
$6.6M
Gross Margin
FSTR
FSTR
NPK
NPK
Q4 25
19.7%
16.9%
Q3 25
22.5%
13.9%
Q2 25
21.5%
15.4%
Q1 25
20.6%
17.5%
Q4 24
22.3%
24.3%
Q3 24
23.8%
18.8%
Q2 24
21.7%
17.3%
Q1 24
21.1%
18.1%
Operating Margin
FSTR
FSTR
NPK
NPK
Q4 25
4.9%
11.4%
Q3 25
6.0%
5.6%
Q2 25
5.3%
5.1%
Q1 25
-2.0%
8.8%
Q4 24
2.4%
17.3%
Q3 24
5.3%
10.0%
Q2 24
3.2%
7.5%
Q1 24
4.5%
8.2%
Net Margin
FSTR
FSTR
NPK
NPK
Q4 25
1.5%
Q3 25
3.1%
4.6%
Q2 25
2.0%
4.3%
Q1 25
-2.2%
7.3%
Q4 24
-0.2%
Q3 24
26.1%
8.8%
Q2 24
2.0%
7.1%
Q1 24
3.6%
8.6%
EPS (diluted)
FSTR
FSTR
NPK
NPK
Q4 25
$0.22
Q3 25
$0.40
Q2 25
$0.27
Q1 25
$-0.20
Q4 24
$-0.04
Q3 24
$3.27
Q2 24
$0.26
Q1 24
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FSTR
FSTR
NPK
NPK
Cash + ST InvestmentsLiquidity on hand
$4.3M
$3.8M
Total DebtLower is stronger
$42.6M
Stockholders' EquityBook value
$175.3M
$395.1M
Total Assets
$330.4M
$500.7M
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FSTR
FSTR
NPK
NPK
Q4 25
$4.3M
$3.8M
Q3 25
$3.4M
$4.6M
Q2 25
$4.2M
$4.8M
Q1 25
$2.6M
$5.5M
Q4 24
$2.5M
$22.7M
Q3 24
$3.1M
$33.2M
Q2 24
$4.0M
$53.4M
Q1 24
$3.1M
$87.9M
Total Debt
FSTR
FSTR
NPK
NPK
Q4 25
$42.6M
Q3 25
$58.6M
Q2 25
$81.4M
Q1 25
$82.3M
Q4 24
$46.8M
Q3 24
$68.4M
Q2 24
$87.0M
Q1 24
$77.9M
Stockholders' Equity
FSTR
FSTR
NPK
NPK
Q4 25
$175.3M
$395.1M
Q3 25
$174.8M
$379.8M
Q2 25
$174.4M
$374.1M
Q1 25
$170.8M
$368.6M
Q4 24
$178.3M
$367.6M
Q3 24
$181.9M
$346.6M
Q2 24
$147.1M
$338.1M
Q1 24
$144.6M
$331.6M
Total Assets
FSTR
FSTR
NPK
NPK
Q4 25
$330.4M
$500.7M
Q3 25
$333.9M
$503.8M
Q2 25
$349.9M
$471.9M
Q1 25
$342.8M
$455.3M
Q4 24
$334.6M
$453.4M
Q3 24
$344.5M
$428.9M
Q2 24
$333.3M
$418.1M
Q1 24
$326.4M
$417.5M
Debt / Equity
FSTR
FSTR
NPK
NPK
Q4 25
0.24×
Q3 25
0.33×
Q2 25
0.47×
Q1 25
0.48×
Q4 24
0.26×
Q3 24
0.38×
Q2 24
0.59×
Q1 24
0.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FSTR
FSTR
NPK
NPK
Operating Cash FlowLast quarter
$22.2M
$13.9M
Free Cash FlowOCF − Capex
$19.8M
$12.4M
FCF MarginFCF / Revenue
12.3%
7.6%
Capex IntensityCapex / Revenue
1.5%
0.9%
Cash ConversionOCF / Net Profit
9.18×
TTM Free Cash FlowTrailing 4 quarters
$25.2M
$-36.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FSTR
FSTR
NPK
NPK
Q4 25
$22.2M
$13.9M
Q3 25
$29.2M
$-24.6M
Q2 25
$10.4M
$-10.9M
Q1 25
$-26.1M
$12.5M
Q4 24
$24.3M
$-7.6M
Q3 24
$24.7M
$-17.5M
Q2 24
$-5.0M
$-33.9M
Q1 24
$-21.4M
$5.6M
Free Cash Flow
FSTR
FSTR
NPK
NPK
Q4 25
$19.8M
$12.4M
Q3 25
$26.4M
$-24.7M
Q2 25
$7.7M
$-13.4M
Q1 25
$-28.7M
$-10.5M
Q4 24
$22.3M
$-11.3M
Q3 24
$21.7M
$-20.3M
Q2 24
$-7.0M
$-34.5M
Q1 24
$-24.2M
$5.2M
FCF Margin
FSTR
FSTR
NPK
NPK
Q4 25
12.3%
7.6%
Q3 25
19.1%
-21.4%
Q2 25
5.4%
-11.1%
Q1 25
-29.4%
-10.2%
Q4 24
17.4%
-8.4%
Q3 24
15.8%
-22.1%
Q2 24
-5.0%
-40.6%
Q1 24
-19.4%
6.7%
Capex Intensity
FSTR
FSTR
NPK
NPK
Q4 25
1.5%
0.9%
Q3 25
2.0%
0.1%
Q2 25
1.9%
2.0%
Q1 25
2.6%
22.2%
Q4 24
1.5%
2.7%
Q3 24
2.2%
3.1%
Q2 24
1.5%
0.8%
Q1 24
2.2%
0.5%
Cash Conversion
FSTR
FSTR
NPK
NPK
Q4 25
9.18×
Q3 25
6.70×
-4.63×
Q2 25
3.61×
-2.12×
Q1 25
1.64×
Q4 24
Q3 24
0.69×
-2.16×
Q2 24
-1.74×
-5.58×
Q1 24
-4.83×
0.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FSTR
FSTR

Rail Technologies And Services Segment$98.0M61%
Over Time Output Method$26.3M16%
Services$19.4M12%
Rail Technologies Products$10.0M6%
Over Time Input Method$8.3M5%

NPK
NPK

Segment breakdown not available.

Related Comparisons